Microplastics in Otitis Media With Effusion Material
Launched by KEREM KÖKOĞLU · Mar 14, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the presence of microplastics in the fluid of the middle ear in patients with a condition called otitis media with effusion (OME). OME is a common ear problem in children that involves fluid buildup behind the eardrum, which can lead to hearing issues and other complications. Researchers are concerned that microplastics, tiny pieces of plastic found in our environment, might contribute to this condition by interacting with biofilms—collections of bacteria that can form in the ear.
The trial is currently looking for participants aged between 6 months to 74 years who have been experiencing OME for at least three months on both sides or nine months on one side. However, individuals with certain conditions, like craniofacial anomalies or those who've had previous ear surgeries, cannot join the study. If you or someone you know qualifies and decides to participate, you can expect to provide a sample of ear fluid for testing, which will help researchers understand the potential link between microplastics and ear health. This study is important for uncovering how environmental factors might affect children's health, particularly regarding ear infections.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients who were followed by bilateral OME at least for three months or one-sided OME at least for 9 months were enrolled to the study
- Exclusion Criteria:
- • Patients with craniofacial anomaly, cleft palate, had history of previous ear surgery were excluded
About Kerem Kökoğlu
Kerem Kökoğlu is a dedicated clinical trial sponsor with a focus on advancing innovative medical research and improving patient outcomes. With a commitment to ethical practices and rigorous scientific standards, Kökoğlu oversees a range of clinical studies aimed at developing new therapies and enhancing existing treatments. His extensive experience in the clinical research landscape, coupled with a strong network of healthcare professionals and research institutions, enables him to drive projects from conception through to successful completion. By prioritizing collaboration and transparency, Kerem Kökoğlu aims to contribute significantly to the advancement of medical science and the well-being of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kayseri, , Turkey
Patients applied
Trial Officials
Mehmet I Şahin, Assoc Prof.
Principal Investigator
TC Erciyes University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported